| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.666 | 36.408 | 32.086 | 14.193 | 23.729 | 21.701 | 26.992 | 31.966 | 29.720 | 32.796 |
| Total Income - EUR | 29.718 | 36.423 | 32.130 | 14.402 | 23.729 | 25.484 | 26.993 | 31.966 | 29.720 | 32.796 |
| Total Expenses - EUR | 18.951 | 23.809 | 22.024 | 13.792 | 23.413 | 24.638 | 24.423 | 27.071 | 28.729 | 31.749 |
| Gross Profit/Loss - EUR | 10.767 | 12.614 | 10.106 | 610 | 317 | 846 | 2.570 | 4.895 | 991 | 1.046 |
| Net Profit/Loss - EUR | 9.876 | 11.522 | 9.417 | 466 | 79 | 610 | 2.300 | 4.575 | 694 | 718 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Umiserum S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.617 | 9.166 | 8.423 | 9.352 | 10.677 | 5.505 | 5.377 | 5.060 | 8.693 | 7.907 |
| Current Assets | 20.634 | 14.538 | 5.977 | 2.638 | 9.488 | 3.096 | 6.802 | 7.174 | 6.344 | 5.629 |
| Inventories | 0 | 0 | 0 | 110 | 107 | 105 | 0 | 0 | 0 | 0 |
| Receivables | 5.278 | 10.004 | 3.016 | 2.516 | 9.080 | 1.858 | 5.250 | 2.023 | 2.753 | 2.352 |
| Cash | 15.356 | 4.535 | 2.961 | 13 | 300 | 1.133 | 1.552 | 5.151 | 3.591 | 3.277 |
| Shareholders Funds | 24.356 | 11.571 | 12.037 | 12.282 | 12.123 | 12.504 | 14.527 | 13.064 | 13.718 | 14.360 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.894 | 12.133 | 2.363 | 2.931 | 11.203 | 6.434 | 7.760 | 9.308 | 8.395 | 3.254 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1813 - 1813" | |||||||||
| CAEN Financial Year |
1813
|
|||||||||
Comments - Umiserum S.r.l.